DD141903A5 - Verfahren zur gewinnung eines enzymbakteriums mit antiviruseigenschaften - Google Patents

Verfahren zur gewinnung eines enzymbakteriums mit antiviruseigenschaften Download PDF

Info

Publication number
DD141903A5
DD141903A5 DD79211058A DD21105879A DD141903A5 DD 141903 A5 DD141903 A5 DD 141903A5 DD 79211058 A DD79211058 A DD 79211058A DD 21105879 A DD21105879 A DD 21105879A DD 141903 A5 DD141903 A5 DD 141903A5
Authority
DD
German Democratic Republic
Prior art keywords
virus
neuraminidase
solution
units
bacterial
Prior art date
Application number
DD79211058A
Other languages
German (de)
English (en)
Inventor
Nicole Simon-Lavoine
Marcel Forgeot
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of DD141903A5 publication Critical patent/DD141903A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD79211058A 1978-02-16 1979-02-16 Verfahren zur gewinnung eines enzymbakteriums mit antiviruseigenschaften DD141903A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH171978 1978-02-16

Publications (1)

Publication Number Publication Date
DD141903A5 true DD141903A5 (de) 1980-05-28

Family

ID=4216998

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79211058A DD141903A5 (de) 1978-02-16 1979-02-16 Verfahren zur gewinnung eines enzymbakteriums mit antiviruseigenschaften

Country Status (16)

Country Link
EP (1) EP0004214A1 (pt)
JP (1) JPS54147911A (pt)
AR (1) AR219372A1 (pt)
AU (1) AU4427879A (pt)
BR (1) BR7900951A (pt)
DD (1) DD141903A5 (pt)
DE (1) DE2905678A1 (pt)
DK (1) DK64379A (pt)
FI (1) FI790483A (pt)
GR (1) GR68088B (pt)
IL (1) IL56679A0 (pt)
NO (1) NO790512L (pt)
OA (1) OA06185A (pt)
PL (1) PL213477A1 (pt)
PT (1) PT69235A (pt)
ZA (1) ZA79697B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579765B1 (en) * 1991-04-09 2000-09-20 Molecular Rx., Inc. Method and composition for the treatment of herpes related disorders
EP0540790B1 (en) * 1991-11-05 1996-09-11 Technochemical Corporation S.A. Method of obtaining monosialogangliosides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (pt) * 1974-03-05 1977-11-04 Science Union & Cie
DE2620649C3 (de) * 1976-05-11 1980-11-06 Behringwerke Ag, 3550 Marburg Immunologisches Adjuvans

Also Published As

Publication number Publication date
DE2905678A1 (de) 1979-12-20
IL56679A0 (en) 1979-05-31
FI790483A (fi) 1979-08-17
AR219372A1 (es) 1980-08-15
PT69235A (fr) 1979-03-01
EP0004214A1 (fr) 1979-09-19
AU4427879A (en) 1979-08-23
NO790512L (no) 1979-08-17
ZA79697B (en) 1980-02-27
DK64379A (da) 1979-08-17
GR68088B (pt) 1981-10-30
BR7900951A (pt) 1979-09-11
JPS54147911A (en) 1979-11-19
OA06185A (fr) 1981-06-30
PL213477A1 (pt) 1979-12-03

Similar Documents

Publication Publication Date Title
DE68908971T2 (de) Verwendung von physiologisch wirksamen Substanzen zur Herstellung von Medikamenten für Gehirn- und Nervenerkrankungen.
DE3027105A1 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors
EP0140134A2 (de) Verfahren zur Herstellung eines biologisch aktiven Extraktes
DE2024586C3 (pt)
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
DE2441454A1 (de) Verfahren zur herstellung eines heilmittels fuer leukaemie
DE3152621C2 (pt)
DE69005978T2 (de) Verwendung von Actinonin zur Herstellung eines Medikamentes zur Inhibierung der Angiogenese.
DE3887686T2 (de) Bakterielle zubereitung für die prophylaxe und behandlung von entzuendungen und allergischen beschwerden.
DE60311595T2 (de) Zusammensetzung zur behandlung von gastrointestinalen beschwerden
DE2048848A1 (de) Verfahren zur Herstellung eines Korn plexes aus RNS und Polysacchand, Verfahren zur Gewinnung der Polysacchand Komponente und ihre Verwendung zur Herstellung von Arzneimitteln
DD141903A5 (de) Verfahren zur gewinnung eines enzymbakteriums mit antiviruseigenschaften
DE3504940C2 (de) Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
Hegyeli et al. Preparation of retine from human urine
CH657989A5 (de) Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
EP0249165B1 (de) Arzneimittel zur Bekämpfung maligner und chronischer Erkrankungen
DE3118148A1 (de) Antiallergisches praeparat und verfahren zu seiner herstellung
DE602004009199T2 (de) Wirkungen von sporoderm-gebrochenen germinationsaktivierten ganoderma-sporen auf die behandlung von rückenmarksverletzungen und die proliferation und/oder differenzierung von neuralen stammzellen in verletztem rückenmark
CN102600210B (zh) 一种复方氢溴酸右美沙芬糖浆剂及其制备方法
DE2508396A1 (de) Verfahren zur gewinnung von virusproteinen, die dabei erhaltenen proteine und diese proteine als wirkstoffe enthaltende arzneimittel
AT392003B (de) Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat
CH640244A5 (en) Biologically active substance
CH640865A5 (de) Glykoproteid des menschlichen urins, verfahren zu seiner herstellung und mittel zur bekaempfung von leukozytopenie.
JPH0665041A (ja) 皮膚外用剤
CN108653729A (zh) 一种阴道泡沫剂及其应用